PUBLICATION
            Zebrafish as a disease model for studying human hepatocellular carcinoma
- Authors
 - Lu, J.W., Ho, Y.J., Yang, Y.J., Liao, H.A., Ciou, S.C., Lin, L.I., Ou, D.L.
 - ID
 - ZDB-PUB-151119-5
 - Date
 - 2015
 - Source
 - World journal of gastroenterology 21: 12042-12058 (Review)
 - Registered Authors
 - Keywords
 - Cancer model, Drug screening, Hepatocellular carcinoma, Liver disease, Zebrafish
 - MeSH Terms
 - 
    
        
        
            
                
- Animals, Genetically Modified
 - Gene Knockout Techniques
 - Zebrafish*/anatomy & histology
 - Zebrafish*/genetics
 - Zebrafish*/metabolism
 - Zebrafish Proteins/genetics
 - Zebrafish Proteins/metabolism
 - Disease Models, Animal
 - Heterografts
 - Animals
 - Humans
 - Gene Expression Regulation, Neoplastic
 - Phenotype
 - Species Specificity
 - Risk Factors
 - Chemical and Drug Induced Liver Injury*/genetics
 - Chemical and Drug Induced Liver Injury*/metabolism
 - Chemical and Drug Induced Liver Injury*/pathology
 - Carcinoma, Hepatocellular*/genetics
 - Carcinoma, Hepatocellular*/metabolism
 - Carcinoma, Hepatocellular*/pathology
 - Carcinoma, Hepatocellular*/therapy
 - Liver Neoplasms*/genetics
 - Liver Neoplasms*/metabolism
 - Liver Neoplasms*/pathology
 - Liver Neoplasms*/therapy
 - Genotype
 
 - PubMed
 - 26576090 Full text @ World J. Gastroenterol.
 
            Citation
        
        
            Lu, J.W., Ho, Y.J., Yang, Y.J., Liao, H.A., Ciou, S.C., Lin, L.I., Ou, D.L. (2015) Zebrafish as a disease model for studying human hepatocellular carcinoma. World journal of gastroenterology. 21:12042-12058.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                Liver cancer is one of the world's most common cancers and the second leading cause of cancer deaths. Hepatocellular carcinoma (HCC), a primary hepatic cancer, accounts for 90%-95% of liver cancer cases. The pathogenesis of HCC consists of a stepwise process of liver damage that extends over decades, due to hepatitis, fatty liver, fibrosis, and cirrhosis before developing fully into HCC. Multiple risk factors are highly correlated with HCC, including infection with the hepatitis B or C viruses, alcohol abuse, aflatoxin exposure, and metabolic diseases. Over the last decade, genetic alterations, which include the regulation of multiple oncogenes or tumor suppressor genes and the activation of tumorigenesis-related pathways, have also been identified as important factors in HCC. Recently, zebrafish have become an important living vertebrate model organism, especially for translational medical research. In studies focusing on the biology of cancer, carcinogen induced tumors in zebrafish were found to have many similarities to human tumors. Several zebrafish models have therefore been developed to provide insight into the pathogenesis of liver cancer and the related drug discovery and toxicology, and to enable the evaluation of novel small-molecule inhibitors. This review will focus on illustrative examples involving the application of zebrafish models to the study of human liver disease and HCC, through transgenesis, genome editing technology, xenografts, drug discovery, and drug-induced toxic liver injury.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping